Secretory carcinoma is generally considered a slow-growing, low-grade malignant tumor, but this report describes a patient with high-grade features who presented with a soft-tissue neck mass.
Nasopharyngeal carcinoma is known for its high potential to metastasize, but breast metastasis is rare. The authors describe the first case of synchronous breast metastases in a male patient.
Carcinosarcomas or malignant mixed tumors of the salivary gland are extremely rare. This report describes the first case of adenoid cystic carcinoma as the carcinomatous component with chondrosarcoma.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
Secretory carcinoma is generally considered a slow-growing, low-grade malignant tumor, but this report describes a patient with high-grade features who presented with a soft-tissue neck mass.
Nasopharyngeal carcinoma is known for its high potential to metastasize, but breast metastasis is rare. The authors describe the first case of synchronous breast metastases in a male patient.
Carcinosarcomas or malignant mixed tumors of the salivary gland are extremely rare. This report describes the first case of adenoid cystic carcinoma as the carcinomatous component with chondrosarcoma.
The surgical landscape for advanced laryngeal cancer (LC) has undergone significant transformations since the first total laryngectomy, carried out in 1873, marking over 150 years of evolution toward strategies aiming to the preservation of the …
Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that …
The combined effect of the increased risk of head and neck cancer with advancing age, along with the improvement in life expectancy results in a marked rise in the prevalence of laryngeal squamous cell carcinoma (LSCC) [ 1 ]. Nowadays, early-stage …
Classification of head and neck tumors has evolved in recent decades including a widespread application of molecular testing in tumors of the salivary glands, sinonasal tract, oropharynx, nasopharynx, and soft tissue. Availability of new molecular …
Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.
An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.
The Internet serves as a widely accessible platform for information, yet the reliability of the information it offers remains uncertain. It has become an indispensable resource for health-related information, with a significant proportion of …
Salivary gland tumors (SGT) constitute less than 3–4% of all head and neck tumors. They form a histologically heterogeneous group, with unpredictable and often highly aggressive clinical behavior. The wide variety of tumor etiology, microscopic …
The surgical landscape for advanced laryngeal cancer (LC) has undergone significant transformations since the first total laryngectomy, carried out in 1873, marking over 150 years of evolution toward strategies aiming to the preservation of the …
Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that …